Author: Bruno Heberto, Aquino; Corona Juan Carlos, Plata; Rubio José Antonio, Castro; Pérez Patricia, Pulido; Rasgado Enrique, Torres; Portano Julieta Danira, Morales; Ãlvarez Enrique Benito, Gómez; Rajme José Alfredo, Merino
Title: ¨ IMPLICATIONS OF MYOCARDIAL INJURY IN MEXICAN HOSPITALIZED PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19) Cord-id: kr7bniih Document date: 2020_9_12
ID: kr7bniih
Snippet: Background Respiratory illnesses is the most common manifestation of Coronavirus disease 2019 (COVID-19); however, myocardial injury has recently emerged as a frequent complication. Methods An observational, longitudinal, prospective, and multicenter study of hospitalized Mexican patients was made. We assessed the prevalence of myocardial injury and its relationship with complications and mortality. Results 254 COVID-19 patients were included. Their average age was 53.8 years old, 167 (65.7%) we
Document: Background Respiratory illnesses is the most common manifestation of Coronavirus disease 2019 (COVID-19); however, myocardial injury has recently emerged as a frequent complication. Methods An observational, longitudinal, prospective, and multicenter study of hospitalized Mexican patients was made. We assessed the prevalence of myocardial injury and its relationship with complications and mortality. Results 254 COVID-19 patients were included. Their average age was 53.8 years old, 167 (65.7%) were male and 87 (34.3%) female. According to troponin levels, two populations were generated, those with and without myocardial injury. There was no difference in gender or age between both groups. However, there was a greater proportion of obesity and hypertension in myocardial injury group. Multivariate logistic regression analysis revealed that obesity (OR 2.029, 95% CI 1.039-3.961; p=0.038), arterial oxygen saturation <90% (OR 2.250, 95% CI 1.216-3.560; p=0.025), and systolic blood pressure <90 mmHg (OR 2.636, 95% CI 1.530-4.343; p=0.042), were directly related to higher levels of troponins. Multivariate cox proportional hazards analysis showed that primary endpoint (mortality) was determined by overweight/obesity (OR 1.290, 95% CI 0.115-0.730; p=0.009), ferritin levels (OR 1.001, 95% CI 1.000-1.001; p<0.001), myocardial injury (OR 3.764, 95% CI 1.307-10.838; p=0.014), septic shock (OR 4.104, 95% CI 1.142-14.132; p=0.024), acute respiratory distress syndrome (OR 3.001, 95% CI 1.008-10.165; p=0.040), and treatment with Hydroxychloroquine/Azithromycin (OR 0.357, 95% IC 0.133-0.955; p=0.040) .Secondary endpoint (Mechanical ventilation risk) was associated to the same factors. Conclusions Myocardial injury represents an increased risk of complications and death in Mexican hospitalized patients with COVID-19.
Search related documents:
Co phrase search for related documents- acute aki kidney injury and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute aki kidney injury and low molecular weight heparin: 1, 2, 3, 4, 5
- acute aki kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute cardiac injury and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute cardiac injury and logistic regression analysis: 1, 2, 3, 4, 5, 6
- acute cardiac injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute myocardial injury and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute myocardial injury and logistic regression analysis: 1, 2, 3
- acute myocardial injury and lymphocyte count: 1, 2
- acute respiratory and administer therapy: 1, 2, 3
- acute respiratory and log rank test kaplan meier curve: 1, 2
- acute respiratory and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and low molecular weight heparin anticoagulant therapy: 1, 2
- acute respiratory and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory distress syndrome and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- acute respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date